Literature DB >> 6186375

Adjuvant chemotherapy of large bowel cancer.

J M Gilbert.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6186375     DOI： 10.1016/s0305-7372(82)80007-8

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN： 0305-7372            Impact factor:   12.111


× No keyword cloud information.
  6 in total

1.  Adjuvant oral Razoxane (ICRF 159) in resectable colo-rectal cancer.

Authors:  M L Slevin; V J Harvey; P F Wrigley
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

2.  Chemotherapy of chemically-induced colorectal tumours.

Authors:  J M Gilbert; E M Thompson; G Slavin; A E Kark
Journal:  J R Soc Med       Date:  1983-06       Impact factor: 5.344

3.  Effect of razoxane on metastases from colorectal cancer.

Authors:  K Hellmann; J Gilbert; M Evans; P Cassell; R Taylor
Journal:  Clin Exp Metastasis       Date:  1987 Jan-Mar       Impact factor: 5.150

4.  Organ culture as a model for investigating the effects of antimetabolites and nucleoside transport inhibitors on rodent colonic mucosa.

Authors:  M Moorghen; P Ince; K J Finney; A J Watson; A L Harris
Journal:  In Vitro Cell Dev Biol       Date:  1991-11

5.  Comparative levels of tissue enzymes concerned in the early metabolism of 5-fluorouracil in normal and malignant human colorectal tissue.

Authors:  P J Finan; P A Koklitis; E M Chisholm; G R Giles
Journal:  Br J Cancer       Date:  1984-11       Impact factor: 7.640

6.  Sensitivity of newly established colorectal cell lines to cytotoxic drugs and monoclonal antibody drug conjugates.

Authors:  L G Durrant; M C Garnett; J Gallego; N C Armitage; K C Ballantyne; R A Marksman; J D Hardcastle; R W Baldwin
Journal:  Br J Cancer       Date:  1987-12       Impact factor: 7.640
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.